nach oben

Urolithiasis

Erschienen in:

01.11.2005 | Invited Review

Hyperoxaluria-induced oxidative stress and antioxidants for renal protection

verfasst von: Saeed R. Khan

Erschienen in: Urolithiasis | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Renal cellular exposure to oxalate (Ox) and/or CaOx crystals leads to the production of reactive oxygen species (ROS), development of oxidative stress followed by injury and inflammation. Renal injury and inflammation appear to play a significant role in stone formation. ROS are produced from many sources and involve a variety of signaling pathways. Tissue culture and animal model studies show that treatments with anti-oxidants and free radical scavengers reduce Ox/CaOx crystal induced injuries. In addition, CaOx crystal deposition in kidneys is significantly reduced by treatments with antioxidants and free radical scavengers, indicating their efficacy. These results point towards a great potential for the therapeutic application of antioxidants and free radical scavengers to reduce stone recurrence particularly after shock wave lithotripsy, which is itself known to generate ROS and cause renal damage.

Danpure CJ, Purdue PE (1995) Primary hyperoxaluria. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York, p 2385

Hatch M, Freel RW, Vaziri ND (1999) Regulatory aspects of oxalate excretion in enteric oxalate elimination. J Am Soc Nephrol 10: S324PubMed

Hackett RL, Shevock PN, Khan SR (1994) Madin-Darby canine kidney cells are injured by exposure to oxalate and to calcium oxalate crystals. Urol Res 22: 197CrossRefPubMed

Koul H, Kenington L, Nair G, Honeyman T, Menon M, Scheid CR (1994) Ox-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem Biophys Res Commun 205: 1632CrossRefPubMed

Koul H, Kenington L, Honeyman T, Jonassen J, Menon M, Scheid CR (1996) Activation of the c-myc gene mediates the mitogenic effects of Ox in LLC-PK1 cells, a line of renal epithelial cells. Kidney Int 50: 1525PubMed

Khan SR (1995) Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23: 71CrossRefPubMed

Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue culture studies. Clin Exp Nephrol 8: 75CrossRefPubMed

Khan SR (2004) Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 98: 55CrossRef

Scheid CR, Koul H, Hill WA, Luber-Narod J, Kennington L, Honeyman T, Jonassen J, Menon M (1996) Ox toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 49: 413PubMed

10.

Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and CaOx nephrolithiasis. J Urol 157: 1059CrossRefPubMed

11.

Thamilselvan S, Hackett RL, Khan SR (2000) Free radical scavengers catalase and superoxide dismutase provide protection from oxalate associated injury to LLC-PK1 and MDCK cells. J Urol 164: 224CrossRefPubMed

12.

Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31: 3PubMed

13.

Drodge W (2001) Free radicals in the physiological control of cell function. Physiol Rev 82: 47

14.

Kamata H, Hirata H (1999) Redox regulation of cellular signalling. Cell Signal 11: 1CrossRefPubMed

15.

Huang H-S, Ma M-C, Chen C-F, Chen J (2003) Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 61: 1123CrossRefPubMed

16.

Tungsanga K,Sriboonlue P, Futrakul P, Yachantha C, Tosukhowong P (2005) Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res (in press)

17.

Khand FD, Gordge MP, Robertson WG, Noronha-Dutra AA, Hothersall JS (2002) Mitochondrial superoxide production during oxalate mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32: 1339CrossRefPubMed

18.

Cao L-C, Honeyman T, Jonassen J, Scheid C (2000) Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells. Kidney Int 57: 2403CrossRefPubMed

19.

Byer K, Khan SR (2005) Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol 173: 640CrossRefPubMed

20.

Toblli JE, Ferder L, Stella I, De Cavanagh MVE, Angerosa M, Inserra F (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168: 1550CrossRefPubMed

21.

Huang H-S, Ma M-C, Chen J, Chen C-F (2002) Changes in the oxidant-antioxidant balance in the kidneys of rats with nephrolithiasis induced by ethylene glycol. J Urol 167: 2584CrossRefPubMed

22.

Chen D H-C, Kaung H-LC, Miller CM, Resnick MI, Marengo SR (2004) Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 94: 637CrossRefPubMed

23.

Cao L-C, Honeyman T, Cooney R, Kennington L, Scheid C R, Jonassen J A, (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66: 1890CrossRefPubMed

24.

Li N, Yi FX, Spurrier JL, Bobrowitz CA, Zou AP (2002) Production of superoxide through NADH oxidase in thick ascending limb of the loop in rat kidney, Am J Physiol 282: F1111

25.

Geiszt M, Kopp JB, Varnai P, Leto TL (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97: 8010CrossRefPubMed

26.

Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK (2002) NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4: 899CrossRefPubMed

27.

Griendling KK, Minieri CA, Ollenrenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141PubMed

28.

James EA, Galceran JM, Raij L (1998) Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54: 775CrossRefPubMed

29.

Umekawa T, Hatanaka Y, Kurita T, Khan SR (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in the rat kidneys. J Am Soc Nephrol 15: 635CrossRefPubMed

30.

Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F (2001) Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166: 275CrossRefPubMed

31.

Umekawa T, Byer KJ, Khan SR (2004) NADPH oxidase as a source of reactive oxygen species in oxalate and calcium oxalate crystal induced injury of renal epithelial cells. In: Kidney stones: inside and out, Proceedings of the 10th International Symposium on Urolithiasis, Hong Kong, 2004, The reprographic unit, Hong Kong Polytechnic University, Hong Kong, p 118

32.

Umekawa T, Byer K, Uemura H, Khan SR (2005) Diphenyleneiodium (DPI) reduces oxalate ions and calcium oxalate monohydrate and brushite crystal-induced up-regulation of MCP-1 in nrk 52e cells. Nephrol Dial Transplant (in press)

33.

Rashid T, Menon M, Thamilselvan S (2004) Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 24: 557CrossRefPubMed

34.

Chaturvedi LS, Koul S, Sekhon A, Bhandari A, Menon M, Koul HK (2002) Oxalate selectively activates the p38 mitoge-activated protein kinase and c-Jun N-terminal kinase signal transduction pathway in renal epithelial cells. J Biol Chem 277: 13321CrossRefPubMed

35.

Koul HK, Menon M, Chaturvedi LS, Koul S, Sekhon A, Bhandari A, Huang M (2002) COM crystals activate the p38 mitoge-activated protein kinase (MAPK) signal transduction pathway in renal epithelial cells. J Biol Chem 277: 36845CrossRefPubMed

36.

Han HJ, Lim MJ, Lee YJ (2004) Oxalate inhibits renal proximal tubule cell proliferation via oxidative stress, p38 MAPK/JNK, and cPLA2 signaling pathways. Am J Physiol Cell Physiol 287: C1058CrossRefPubMed

37.

Jonassen JA, Cao LC, Honeyman T, Scheid CR(2003) Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 13: 55CrossRefPubMed

38.

Antus B, Exton MS, Rosivall L (2001) Angiotensin II: a regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 14: 25PubMed

39.

Toblli JE, Ferder L, Angerosa M, Inserra F (1999) Effects of amlodipine on tubulointerstitial lesions in normotensive hyperoxaluric rats. Hypertension 34: 854PubMed

40.

Khan SR, Kok DJ (2004) Modulators of urinary stone formation. Front Biosci 9: 1450PubMed

41.

Khan SR, Byer KJ, Thamilselvan S, Hackett RL, McCormack WT, Benson NA, Vaughn KL, Erdos GW (1999) Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells. J Am Soc Nephrol 10: S457PubMed

42.

Miller C, Kennington L, Cooney R, Kohjimoto Y, Cao LC, Honeyman T, Pullman J, Jonassen J, Scheid C (2000) Oxalate toxicity in renal epithelial cells: characteristics of apoptosis and necrosis. Toxicol Pharmacol 162: 132CrossRef

43.

Khan SR, Finlayson B, Hackett RL (1982) Experimental calcium oxalate nephrolithiasis in the rat, role of renal papilla. Am J Pathol 107: 59PubMed

44.

Khan SR (1995) Experimental CaOx nephrolithiasis and the formation of human urinary stones. Scanning Microsc 9: 89PubMed

45.

Fasano JM, Khan SR (2001) Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int 59: 169CrossRefPubMed

46.

Riese RJ, Mandel NS, Wiessner JH, Mandel GS, Becker CJ, Kleinman JC (1992) Cell polarity and CaOx crystal adherence to cultured collecting duct cells. Am J Physiol 262: F177PubMed

47.

Verkoelen CF, Van der Broom BG, Houtsmuller AB, Schroeder FH, Romijn JC (1998) Increased CaOx monohydrate crystal binding to injured renal epithelial cells in culture. Am J Physiol 274: F958PubMed

48.

Bigelow MW, Wienner JH, Kleinman JC, Mandel NS (1999) Surface exposure of PS increases CaOx crystal attachment to IMCD cells. Am J Physiol 272: F55

49.

Wiessner JH, Hasegawa AT, Hung LY, Mandel NS (1999) Oxalate-induced exposure of PS on surface of renal epithelial cells in culture. J Am Soc Nephrol 10: S441PubMed

50.

Thamilselvan S, Selvam R (1997) Effect of vitamin E and mannitol on renal calcium oxalate retention in experimental nephrolithiasis. Indian J Biochem Biophys 34: 319PubMed

51.

Kumar S, Selvam R (2003) Supplementation of vitamin E and selenium prevents hyperoxaluria in experimental urolithic rats. J Nutr Biochem 14: 306CrossRefPubMed

52.

Selvam R, Ravichandran V (1993) Restoration of tissue antioxidants and prevention of renal stone deposition in vitamin B6 deficient rats fed with vitamin E or methionine. Indian J Exp Biol 31: 882PubMed

53.

Muthukumar A, Selvam R (1998) Role of glutathione on renal mitochondrial status in hyperoxaluria. Mol Cell Biochem 185: 77CrossRefPubMed

54.

Ito Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K (2005) Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 173: 271PubMed

55.

Umekawa T, Chegini N, Khan SR (2002) Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by rnal epithelial cells. Kidney Int 61: 105CrossRefPubMed

56.

Pearle MS (2001) Prevention of nephrolithiasis. Curr Opin Nephrol Hypertens 10: 203PubMed

57.

Vaziri ND (2004) Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 13: 93PubMed

58.

Griendling KK, Fitzgerald GA (2004) Oxidative stress and cardiovascular injury. Part II: animal and human studies. Circulation 108: 2034CrossRef

59.

Meagher EA (2003) Treatment of atherosclerosis in the new millennium: is there a role for vitamin E? Prev Cardiol Spring 6(2): 85

60.

Hasnain BI, Mooradian AD (2004) Recent trials of antioxidant therapy: what should we be telling our patients? Cleve Clin J Med 71: 327PubMed

61.

Baxmann AC, Mendonca COG, Heilberg IP (2003) Effect of vitamin C supplements on urinary oxalate and pH in calcium oxalate stone forming patients. Kidney Int 63: 1066CrossRefPubMed

Titel: Hyperoxaluria-induced oxidative stress and antioxidants for renal protection
verfasst von: Saeed R. Khan
Publikationsdatum: 01.11.2005
Verlag: Springer-Verlag
Erschienen in: Urolithiasis / Ausgabe 5/2005
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-005-0492-4

Neu im Fachgebiet Urologie

22.04.2024 | Prostatakarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Hyperoxaluria-induced oxidative stress and antioxidants for renal protection

Abstract

Neu im Fachgebiet Urologie

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Urologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2005

An overview of the role of genotyping in the diagnosis of the primary hyperoxalurias

Renal cell adaptation to oxalate

Pitfalls in the management of patients with primary hyperoxaluria: a urologist’s perspective

NF-κB and chemokine-cytokine expression in renal tubulointerstitium in experimental hyperoxaluria. Role of the renin-angiotensin system

Problems in the investigation of urine from patients suffering from primary hyperoxaluria type 1

Oxalate toxicity in renal cells

Neu im Fachgebiet Urologie

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Urologie